VEA
RPTP

Virtus ETF Advisers’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Virtus ETF Advisers’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-114,022
Closed -$1.02M – 207
2016
Q3 		$1.02M Buy
114,022
+14,368
+14% +$102K 0.49% 33
2016
Q2 		$535K Sell
99,654
-27,215
-21% -$140K 0.4% 46
2016
Q1 		$584K Buy
+126,869
New +$510K 0.8% 28

Virtus ETF Advisers's RPTP Position: Q4 2016 in Review

Virtus ETF Advisers sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 114,022 shares — an estimated $1.02M sold.

Virtus ETF Advisers first reported a position in RPTP in Q1 2016 and held it in 3 quarters. The position peaked at $1.02M in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • Virtus ETF Advisers reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
  • Virtus ETF Advisers sold 114,022 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $1.02M.
  • Virtus ETF Advisers first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q1 2016 and held it in 3 quarters.
  • Virtus ETF Advisers's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $1.02M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.

Based on Virtus ETF Advisers's 13F filing for Q4 2016, filed 14 Feb 2017.